Drug-induced Physeal Abnormalities in Preclinical Toxicity Studies
نویسندگان
چکیده
منابع مشابه
Drug-Eluting Stents in Preclinical Studies
The arrival of drug-eluting stents raises important questions about preclinical evaluation of devices and the optimal means of predicting clinical safety and efficacy. The Interventional, Regulatory, Commercial, and Scientific communities have all asked for assistance in defining criteria for device evaluation. This document is an integrated view of requirements for evaluating drug-eluting sten...
متن کاملDrug-induced liver toxicity studies: research into human metabolites clarifies their role in drug development.
On January 1, 2014, Professor Hiroshi Yamazaki became the fourth Editor-in-Chief of Drug Metabolism and Pharmacokinetics (DMPK), the official journal of the Japanese Society for the Study of Xenobiotics (JSSX). The former Editors-in-Chief, Professors Masahiro Hayashi, Kan Chiba, and Ikumi Tamai, and their editorial teams did a tremendous job in setting up and developing DMPK into the successful...
متن کاملPerformance of novel kidney biomarkers in preclinical toxicity studies.
The kidney is one of the main targets of drug toxicity, but early detection of renal damage is often difficult. As part of the InnoMed PredTox project, a collaborative effort aimed at assessing the value of combining omics technologies with conventional toxicology methods for improved preclinical safety assessment, we evaluated the performance of a panel of novel kidney biomarkers in preclinica...
متن کاملPreclinical rodent toxicity studies for long term use of ceftriaxone
A 6-month rodent toxicology and pharmacokinetic (PK) study was performed to provide supportive safety data for long-term use of intravenous ceftriaxone in a clinical trial in patients with amyotrophic lateral sclerosis (ALS). Ceftriaxone was administered by subcutaneous injection at up to 2 g/kg/day to Sprague-Dawley Crl:CD (SD) rats. Ceftriaxone was found to be safe and well tolerated. Specifi...
متن کاملGauging reactive metabolites in drug-induced toxicity.
Over the past decades, it has become abundantly clear that enzymes evolved to detoxify and eliminate foreign chemicals from the body, occasionally generate highly reactive metabolites which have toxicological implications. To decrease the probability of late clinical failure or market withdrawal, there has been an increased prioritization on understanding key metabolic processes that might caus...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Toxicologic Pathology
سال: 2017
ISSN: 0192-6233,1533-1601
DOI: 10.1177/0192623317713319